11 – 20 of 156
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Amplification of ERBB2 (HER2) in embryonal rhabdomyosarcoma : A potential treatment target in rare cases?
(
- Contribution to journal › Article
-
Mark
Merged testing for colorectal cancer syndromes and re-evaluation of genetic variants improve diagnostic yield : Results from a nationwide prospective cohort
(
- Contribution to journal › Article
-
Mark
N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL)
(
- Contribution to journal › Article
- 2021
-
Mark
Clinical and genomic characterization of patients diagnosed with the provisional entity Acute myeloid leukemia with BCR-ABL1, a Swedish population-based study
(
- Contribution to journal › Article
-
Mark
Sister chromatid cohesion defects are associated with chromosomal copy number heterogeneity in high hyperdiploid childhood acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
Single-cell sequencing in translational cancer research and challenges to meet clinical diagnostic needs
(
- Contribution to journal › Scientific review
-
Mark
Genomic and transcriptomic characterization of desmoplastic small round cell tumors
(
- Contribution to journal › Article
- 2020
-
Mark
Deep sequencing of myxoinflammatory fibroblastic sarcoma
(
- Contribution to journal › Article
-
Mark
Farewell message from the Editor-in-Chief of Genes, Chromosomes & Cancer
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
SFPQ-ABL1-positive B-cell precursor acute lymphoblastic leukemias
2020) In Genes, Chromosomes and Cancer(
- Contribution to journal › Letter